Tetraphase Pharmaceuticals to Present at Upcoming Conferences

WATERTOWN, Mass., June 16, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (Nasdaq: TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant (MDR) infections, today announced that the company will present at the following upcoming conferences:

• Craig Thompson, Chief Operating Officer, will present at the 2015 BIO International Convention on Thursday, June 18th at 11:15 a.m. Eastern Time at the Pennsylvania Convention Center in Philadelphia, PA  
• Guy Macdonald, Tetraphase President and Chief Executive Officer, will present at the 2015 JMP Securities Life Sciences Conference on Tuesday, June 23rd at 3:00 p.m. Eastern Time at The St. Regis in New York City.

A live audio webcast of the JMP presentation will be available on the company's website at http://ir.tphase.com/events.cfm.  An archived presentation will be available for 90 days.

About Tetraphase Pharmaceuticals, Inc.

Tetraphase is a clinical-stage biopharmaceutical company using its proprietary chemistry technology to create novel antibiotics for serious and life-threatening MDR bacterial infections, including those caused by many of the MDR Gram-negative bacteria highlighted as urgent public health threats by the CDC. Tetraphase has created more than 3,000 novel tetracycline analogs using its proprietary technology platform. Tetraphase's pipeline includes eravacycline, a broad-spectrum intravenous and oral antibiotic that is being evaluated in phase 3 clinical trials, and two preclinical antibiotic candidates, TP-271 and TP-6076. Please visit www.tphase.com for more company information.

CONTACT: Investor Contacts:
         Tetraphase Pharmaceuticals
         Teri Dahlman
         617-600-7040
         [email protected]

         Argot Partners
         Susan Kim
         212-600-1902
         [email protected]

         Media Contact:
         Sam Brown Inc.
         Mariesa Kemble
         608-850-4745
         [email protected]

You May Also Be Interested In

• Best Crypto Portfolio: Genesis Wallet Wakes After 11 Years While Pepeto Races Toward Listing Day
• Ibogaine by David Dardashti Proposes Medical Off-Ramp for Displaced Kratom Users Amid Global Bans, Urges Expansion of Right to Try Policy
• Anderson Bradshaw Tax Consulting Expands Tax Resolution Focus as IRS Penalty Relief Changes Encourage Earlier Action